Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial. (Q36542990)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 September 2009

Language	Label	Description	Also known as
English	Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.	scientific article published on 14 September 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

based on heuristic

inferred from title

S. Vincent Rajkumar

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

1

object named as

Morie A Gertz

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Rafat Abonour

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

Leonard T Heffner

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

Philip R Greipp

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

Hajime Uno

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

0 references

publication date

14 September 2009

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

147

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

677-680

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548235

30 September 2017

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548235

30 September 2017

Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548235

30 September 2017

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548235

30 September 2017

Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2009.07892.X

21 January 2018

Waldenström macroglobulinaemia.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2009.07892.X

21 January 2018

Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2009.07892.X

21 January 2018

Extended rituximab therapy in Waldenström's macroglobulinemia.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2009.07892.X

21 January 2018

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2009.07892.X

21 January 2018

Treatment of Waldenstrom's Macroglobulinemia with Rituximab: Prognostic Factors for Response and Progression

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2009.07892.X

21 January 2018

CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19751237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19751237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2009.07892.X

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19751237 AND SRC:MED&resulttype=core&format=json

7 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36542990&oldid=2111224007"